Ocular pharmacokinetics of tivozanib eye drops in patients with neovascular age-related macular degeneration: comparison with phase 1 trials of oral tivozanib in solid tumors

Abstract Intravitreal anti-vascular endothelial growth factor (VEGF) therapy is the standard treatment for neovascular age-related macular degeneration (nAMD) but is invasive and burdensome for patients. To overcome these obstacles, tivozanib, a pan–VEGF receptor inhibitor approved for renal cell ca...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Shinya Horita, Mayumi Saki, Sotaro Takigawa, Yasumasa Kanai, Kenta Murotani, Fumi Gomi
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2026-04-01
Цуврал:	International Journal of Retina and Vitreous
Нөхцлүүд:	Choroid Hypertension Pharmacokinetics Receptors, vascular endothelial growth factor Retina Tivozanib
Онлайн хандалт:	https://doi.org/10.1186/s40942-026-00848-9
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!